Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
about
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicityParkinson's disease and immune system: is the culprit LRRKing in the periphery?Using gene expression signatures to identify novel treatment strategies in gulf war illnessRegulation of LRRK2 expression points to a functional role in human monocyte maturationPathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue.Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.LRRK2 function on actin and microtubule dynamics in Parkinson diseaseCurrent status and future directions of gene expression profiling in Parkinson's disease.Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortexDecreased expression of B cell related genes in leukocytes of women with Parkinson's disease.Low-variance RNAs identify Parkinson's disease molecular signature in bloodBlood transcriptomics of drug-naïve sporadic Parkinson's disease patients.Monoclonal antibodies to discriminate the EF hand containing calcium binding adaptor proteins EFhd1 and EFhd2.Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease.Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits.Considerations regarding the etiology and future treatment of autosomal recessive versus idiopathic Parkinson disease.Gene expression profiling in human neurodegenerative disease.Insights into LRRK2 function and dysfunction from transgenic and knockout rodent models.Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions?LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesisGene expression profiling predicts pathways and genes associated with Parkinson's disease.Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.Physiological and pathophysiological functions of Swiprosin-1/EFhd2 in the nervous system.Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease.A review of genome-wide transcriptomics studies in Parkinson's disease.Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles.Analysis of blood-based gene expression in idiopathic Parkinson disease.From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson's Disease Patients.Partial Depletion of Peripheral M1 Macrophages Reverses Motor Deficits in MPTP-Treated Mouse by Suppressing Neuroinflammation and Dopaminergic Neurodegeneration.
P2860
Q24296968-2415F798-69BA-4EC2-ACF5-FCB6DCB6ED2CQ27687171-E5B8468C-82A4-4EAF-9EDE-D50E58AB9B81Q28397964-908E4FA9-7FC8-42D9-892D-C5EDB07B7DF7Q28743193-61B21102-A643-4BA6-A342-D893424F8CAEQ31028020-5967F21E-33B0-4064-B55B-20436729999AQ34230271-719E744E-3827-4183-8462-2CF5CE677415Q34280111-AFDF7E57-718D-4851-87BF-83C301A12BE1Q34612367-C388ABD1-39BB-41D2-B984-1A1EA12B33B6Q34994699-B468231B-D563-48F2-B4A3-411B0DB40874Q35290033-356AEE1A-62F3-47A0-8EA4-1B5ABFB11509Q35630163-CB51F800-0275-458B-AE1F-40756664CD36Q35824982-75337F28-3C92-441D-839C-E7823C838A06Q37069751-937F79EC-F811-464B-896C-0D1B2692AE41Q37383525-798AF555-1F9C-4389-B7F1-5C8DFC1E7B6AQ37729558-6693C5B2-9E36-4363-836C-FB5D533756F4Q37999105-5C01F7F0-E788-4B94-9EB7-7A77A9F163E9Q38006645-22EF9FEE-0BA8-4998-9C16-7ACBF1A5AA6AQ38034387-022454ED-051C-4B38-9C7F-6CD824C73ED4Q38044434-B38763AB-465D-4710-8EA3-01D79143C43CQ38044437-A9C75ACD-BEBF-43FC-AAE6-AA222BC9B0A2Q38218398-C30A3E1C-3BD5-4086-8A47-7930E90ADD1DQ38459136-83021C5D-FD78-4540-BFA1-F68661039F4FQ38909797-371C37A9-A0AD-41C1-ACAF-D6E9D1AA6E8CQ38925223-64BB93AB-2892-436D-85ED-03B276878340Q39227299-A56BE9C0-4F1F-4B53-A196-E54A32375BD9Q41385214-F3B7273F-A575-4355-BB74-E3040B11B6E3Q42778276-AB2E71E1-7055-400F-A3C6-DE1FE77CAD8FQ45607380-AE67F06B-DF6D-4402-B9E4-58F1464D27E3Q47976347-FC83805A-D67F-46D0-847A-D60469EA53A3Q49197356-06F10FA5-09F1-46AA-83A5-D310E3715BCBQ54325456-7B0DA0D4-30ED-4F76-B90E-1D53A8777786Q55420860-1448723A-4F84-4C8A-9C47-69C6AB876D0B
P2860
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
@en
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
@nl
type
label
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
@en
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
@nl
prefLabel
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
@en
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
@nl
P2093
P50
P1476
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
@en
P2093
Alain Destée
Alexandre Kreisler
Aurélie Duflot
Bernard Frigard
Christel Vanbesien-Mailliot
Dorota Hamalek
Frédéric Leprêtre
Jean-Pierre Kerckaert
Lydie Larvor
Nawal Waucquier
P304
P356
10.1016/J.NEUROBIOLAGING.2009.10.016
P577
2010-01-22T00:00:00Z